タンパク質精製・分離市場 - 世界の産業規模、シェア、動向、機会、予測：用途別、製品別、技術別、地域別、競合、2019-2029年

タンパク質精製・分離の世界市場規模は2023年に82億1,000万米ドルとなり、予測期間では2029年までCAGR 9.89%で着実な成長が予測されています。

世界のタンパク質精製・分離市場は、研究、診断、治療、工業プロセスにおける様々な用途のためのタンパク質の抽出と精製に焦点を当てた、バイオテクノロジーと製薬産業における重要な分野です。創薬、バイオ医薬品生産、診断目的の高品質タンパク質への需要が高まる中、市場は近年大幅な成長を遂げています。

市場概要
予測期間	2025-2029
市場規模：2023年	82億1,000万米ドル
市場規模：2029年	144億米ドル
CAGR：2024年-2029年	9.89%
急成長セグメント	機器
最大市場	北米

プロテオミクス研究の進展、医薬品研究開発への投資の増加、標的タンパク質を用いた治療が必要とされる慢性疾患の増加などが、この成長を牽引する主な要因です。同市場は、細胞溶解液、組織、培養液などの複雑な生物学的サンプルからタンパク質を分離・精製するために設計された幅広い技術と製品を包含しています。クロマトグラフィー、電気泳動、沈殿法のような伝統的な方法は、効率、自動化、スループットにおいて著しい進歩を遂げたとはいえ、広く使用され続けています。

アフィニティーベースの精製、膜ろ過、タンパク質結晶化などの新しい技術は、その特異性、拡張性、より高い収率と純度でタンパク質を精製する能力により、人気を集めています。同市場はまた、様々な治療用途で組換えタンパク質の採用が増加しており、製品の品質と安全性に関する厳しい規制要件を満たすための効率的な精製プロセスに対するニーズが高まっていることも影響しています。北米と欧州は、確立されたバイオ医薬品産業、強固な研究インフラ、プロテオミクス研究への多額の投資により、従来から世界市場で突出した地位を占めてきました。

自動精製システム、ハイスループットプラットフォーム、統合ソフトウェアソリューションなどの技術的進歩は、タンパク質精製ワークフローに革命をもたらし、研究者が実験においてより高いスループット、再現性、効率を達成することを可能にしています。個別化医療と精密治療に対する需要の高まりは、特定のタンパク質標的、疾患適応、治療様式に合わせた革新的な精製技術の開発を促進しています。市場はまた、高度な精製システムに伴う高額な初期費用、特定のクラスのタンパク質を精製することの複雑さ、精製プロセスの検証と標準化に関連する規制上のハードルといった課題にも直面しています。

主な市場促進要因

バイオ医薬品産業の成長

技術の進歩

慢性疾患の増加

主な市場課題

複雑なサンプルマトリックスと不均一性

コストと時間のかかるプロセス

拡張性と再現性

主な市場動向

プロテオミクス研究の拡大

個別化医療への注目の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のタンパク質精製・分離市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（薬物スクリーニング、バイオマーカー発見、タンパク質間相互作用の研究、診断）
  • 製品別（機器、消耗品）
  • 技術別（限外ろ過、沈殿、クロマトグラフィー、電気泳動、ウェスタンブロッティング、その他）
  • 地域別
  • 企業別（2023）
• 市場マップ
  • 用途別
  • 製品別
  • 技術別
  • 地域別

第6章 アジア太平洋地域のタンパク質精製・分離市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 製品別
  • 技術別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のタンパク質精製・分離市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 製品別
  • 技術別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のタンパク質精製・分離市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 製品別
  • 技術別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のタンパク質精製・分離市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 製品別
  • 技術別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのタンパク質精製・分離市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 製品別
  • 技術別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のタンパク質精製・分離市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• QIAGEN N.V
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• GE HealthCare Technologies Inc.
• Promega Corporation
• Norgen Biotek Corp.
• Abcam Limited
• Danaher Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Protein Purification and Isolation Market was valued at USD 8.21 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 9.89% through 2029. The global protein purification and isolation market is a vital sector within the biotechnology and pharmaceutical industries, focused on the extraction and purification of proteins for various applications in research, diagnostics, therapeutics, and industrial processes. With an increasing demand for high-quality proteins for drug discovery, biopharmaceutical production, and diagnostic purposes, the market has witnessed substantial growth in recent years.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 8.21 Billion
Market Size 2029	USD 14.40 Billion
CAGR 2024-2029	9.89%
Fastest Growing Segment	Instruments
Largest Market	North America

Key factors driving this growth include advancements in proteomics research, rising investments in pharmaceutical R&D, and the growing prevalence of chronic diseases necessitating targeted protein-based therapies. The market encompasses a wide range of techniques and products designed to isolate and purify proteins from complex biological samples, such as cell lysates, tissues, or culture media. Traditional methods like chromatography, electrophoresis, and precipitation techniques continue to be widely used, albeit with significant advancements in efficiency, automation, and throughput.

Novel techniques such as affinity-based purification, membrane filtration, and protein crystallization have gained traction due to their specificity, scalability, and ability to purify proteins with higher yields and purity. The market is also influenced by the increasing adoption of recombinant proteins in various therapeutic applications, driving the need for efficient purification processes to meet stringent regulatory requirements for product quality and safety. North America and Europe have traditionally held prominent positions in the global market, owing to established biopharmaceutical industries, robust research infrastructure, and substantial investments in proteomics research.

Technological advancements such as automated purification systems, high-throughput platforms, and integrated software solutions are revolutionizing protein purification workflows, enabling researchers to achieve higher throughput, reproducibility, and efficiency in their experiments. The increasing demand for personalized medicine and precision therapies is driving the development of innovative purification technologies tailored to specific protein targets, disease indications, and therapeutic modalities. The market also faces challenges such as high upfront costs associated with sophisticated purification systems, the complexity of purifying certain classes of proteins, and regulatory hurdles related to the validation and standardization of purification processes.

Key Market Drivers

Growing Biopharmaceutical Industry

The growing biopharmaceutical industry is a significant driver behind the expansion of the global protein purification and isolation market. Biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and vaccines, have emerged as key therapeutic modalities for treating various diseases, including cancer, autoimmune disorders, and infectious diseases. As a result, the demand for advanced protein purification and isolation technologies has surged, fueling market growth.

One of the primary reasons for the increasing demand for protein purification and isolation technologies within the biopharmaceutical sector is the complexity of biologics manufacturing. Unlike traditional small-molecule drugs, biopharmaceuticals are produced using living organisms or biological systems, such as bacteria, yeast, mammalian cells, or transgenic animals. The purification of these biomolecules from complex biological mixtures requires sophisticated techniques capable of isolating the target protein with high yield, purity, and activity.

Stringent regulatory requirements governing the production of biopharmaceuticals necessitate the use of robust purification and isolation processes to ensure product safety, efficacy, and consistency. Protein purification plays a critical role in removing impurities, such as host cell proteins, DNA, endotoxins, and aggregates, which could compromise the quality and safety of the final drug product. Biopharmaceutical companies prioritize investing in state-of-the-art purification technologies to meet regulatory standards and ensure the production of high-quality biologics.

The expanding pipeline of biopharmaceutical products further drives the demand for protein purification and isolation solutions. With advancements in biotechnology and genetic engineering, researchers are developing an increasing number of biologics targeting various diseases and therapeutic areas. Each new biopharmaceutical candidate requires customized purification strategies tailored to its unique properties and production system, creating opportunities for companies offering innovative purification technologies and services.

Technological Advancements

Technological advancements have been pivotal in driving the growth of the global protein purification and isolation market, revolutionizing the efficiency, scalability, and purity levels of these processes. As the demand for purified proteins continues to grow across various industries such as biopharmaceuticals, academic research, and biotechnology, innovative technologies play a crucial role in meeting these evolving needs. One significant advancement in protein purification and isolation is the development of chromatography techniques. High-performance liquid chromatography (HPLC), affinity chromatography, ion exchange chromatography, and size exclusion chromatography are among the widely used chromatographic methods for protein separation. Continuous improvements in column design, stationary phases, and detection systems have led to enhanced resolution, selectivity, and throughput, allowing researchers to isolate proteins with higher purity and yield.

Electrophoresis techniques, including gel electrophoresis and capillary electrophoresis, have also undergone significant advancements, enabling precise separation and characterization of proteins based on their size, charge, and mobility. The introduction of technologies such as SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and 2D electrophoresis has facilitated the analysis of complex protein mixtures, paving the way for proteomic studies and biomarker discovery.

The integration of automation and robotics into protein purification workflows has streamlined the process, reducing manual labor and increasing throughput. Automated liquid handling systems, robotic sample preparation platforms, and high-throughput purification systems enable researchers to process large numbers of samples efficiently while maintaining reproducibility and accuracy. These advancements have not only improved productivity but also reduced operational costs and minimized the risk of human error.

Another notable technological advancement driving the protein purification and isolation market is the development of novel affinity ligands and resins. Affinity chromatography, which relies on specific interactions between a target protein and its ligand, has gained popularity due to its high selectivity and purity. The discovery and design of new affinity ligands, such as antibodies, aptamers, and engineered peptides, have expanded the range of proteins that can be effectively purified, contributing to market growth.

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases worldwide is a significant driver behind the growth of the global protein purification and isolation market. Chronic diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune diseases have become leading causes of morbidity and mortality globally, posing significant challenges to healthcare systems. In response to this growing health burden, there is an increasing emphasis on developing targeted therapeutics and personalized treatment approaches, driving the demand for purified proteins for research, diagnosis, and drug development.

Proteins play crucial roles in the pathogenesis, diagnosis, and treatment of chronic diseases. Understanding the structure, function, and interactions of disease-related proteins is essential for elucidating disease mechanisms and identifying potential therapeutic targets. Protein purification and isolation techniques enable researchers to isolate and study specific proteins implicated in chronic diseases, facilitating the discovery and development of novel therapeutics.

Biomarker discovery is a key area where protein purification and isolation technologies are instrumental in addressing the challenges associated with chronic diseases. Biomarkers are measurable indicators of biological processes or disease states and play essential roles in disease diagnosis, prognosis, and monitoring. Proteomic studies aimed at identifying disease-specific biomarkers require sophisticated purification techniques to isolate low-abundance proteins from complex biological samples such as blood, urine, or tissue extracts.

The growing demand for personalized medicine and precision oncology further drives the need for purified proteins in diagnostic and therapeutic applications. Proteomic profiling of patient samples enables the identification of molecular signatures associated with specific diseases or patient subgroups, facilitating personalized treatment strategies. Protein purification technologies play a crucial role in isolating and characterizing disease-specific biomarkers and therapeutic targets, thereby supporting the development of targeted therapies tailored to individual patients.

Key Market Challenges

Complex Sample Matrices and Heterogeneity

One of the primary challenges faced by protein purification and isolation processes is the complexity of sample matrices and the heterogeneity of protein mixtures. Biological samples, such as cell lysates, tissue extracts, and blood plasma, contain a diverse array of proteins with varying sizes, charges, and abundances. This complexity makes it challenging to isolate target proteins of interest while effectively removing contaminants and impurities.

The heterogeneity of protein mixtures poses challenges in achieving high purity and yield during purification processes. Variations in protein expression levels, post-translational modifications, and isoform differences further complicate purification strategies, leading to decreased efficiency and reproducibility. Overcoming these challenges requires the development of innovative purification technologies capable of selectively isolating target proteins from complex biological samples while minimizing non-specific binding and interference from impurities.

Cost and Time Intensive Processes

Protein purification and isolation processes are often time-consuming and cost-intensive, presenting significant challenges for researchers and biopharmaceutical companies. Traditional purification methods, such as chromatography and electrophoresis, require expensive equipment, consumables, and specialized reagents, contributing to high operational costs. These processes involve multiple steps, including sample preparation, chromatographic separation, and purification optimization, prolonging the time required to obtain purified proteins.

The cost and time constraints associated with protein purification and isolation hinder research progress and drug development timelines, limiting the scalability and commercialization of biopharmaceutical products. To address these challenges, there is a growing need for the development of cost-effective and time-efficient purification technologies that streamline workflows, reduce resource consumption, and improve process productivity.

Scalability and Reproducibility

Scalability and reproducibility are critical challenges in protein purification and isolation, particularly for biopharmaceutical manufacturing and large-scale production. Many purification techniques that work effectively at the laboratory scale may not be easily scalable to industrial production levels due to limitations in equipment capacity, column size, and process optimization.

Achieving consistent purification results across different scales is essential for ensuring product quality, regulatory compliance, and manufacturing efficiency. Variations in protein yields, purity levels, and process performance between laboratory and large-scale production settings can pose significant challenges for biopharmaceutical companies.

Key Market Trends

Expansion of Proteomics Research

Proteomics research, the large-scale study of proteins and their functions, has witnessed exponential growth in recent years, driven by advancements in technology, increased funding, and growing interest in understanding the molecular basis of diseases. This expansion of proteomics research is not only reshaping our understanding of biology but also fueling the demand for advanced protein purification and isolation technologies, thus driving the growth of the global protein purification and isolation market.

One of the key drivers behind the expansion of proteomics research is the advent of high-throughput technologies such as mass spectrometry, protein microarrays, and next-generation sequencing. These technologies enable researchers to analyze thousands of proteins simultaneously, allowing for comprehensive profiling of cellular proteomes and identification of protein biomarkers associated with diseases. As proteomics studies become more complex and data-intensive, there is a growing need for reliable and efficient protein purification and isolation methods to obtain high-quality samples for analysis.

The increasing adoption of proteomics research in various fields, including biomedical research, drug discovery, and personalized medicine, is driving the demand for purified proteins. Proteomics studies play a crucial role in identifying disease biomarkers, elucidating disease mechanisms, and discovering potential drug targets. Protein purification and isolation technologies are essential for isolating specific proteins of interest from complex biological samples, enabling researchers to study their structure, function, and interactions in detail.

The expansion of proteomics research is also fueled by the growing availability of genomic and proteomic databases, as well as bioinformatics tools for data analysis and interpretation. These resources facilitate the integration of proteomics data with other omics data, such as genomics and transcriptomics, enabling researchers to gain deeper insights into biological systems and disease processes. However, to fully leverage the wealth of information generated by proteomics studies, researchers require high-quality purified proteins for downstream analysis, highlighting the importance of protein purification and isolation technologies.

Increased Focus on Personalized Medicine

Personalized medicine, also known as precision medicine, has emerged as a revolutionary approach to healthcare, aiming to tailor medical treatments to individual patients based on their genetic makeup, lifestyle, and environmental factors. This paradigm shift in medicine is not only transforming patient care but also driving the demand for advanced protein purification and isolation technologies, thereby boosting the growth of the global protein purification and isolation market.

One of the key drivers behind the increased focus on personalized medicine is the growing recognition of the heterogeneity of diseases and treatment responses among patients. Traditional one-size-fits-all approaches to drug development and treatment may not always be effective, as individual patients may exhibit different genetic variations, molecular profiles, and disease pathways. Personalized medicine seeks to address these complexities by identifying biomarkers, therapeutic targets, and treatment strategies tailored to each patient's unique characteristics.

Proteomics research plays a crucial role in personalized medicine by elucidating the molecular basis of diseases and identifying biomarkers that can inform treatment decisions. Protein biomarkers are indicators of biological processes or disease states and can be used for disease diagnosis, prognosis, and monitoring. Protein purification and isolation technologies are essential for isolating specific proteins of interest from patient samples, such as blood, urine, or tissue biopsies, for biomarker discovery and validation.

Segmental Insights

Application Insights

Based on the application, protein-protein segment emerged as the dominant segment in the Global Protein Purification and Isolation market in 2023. Protein-protein interactions play a fundamental role in numerous biological processes, including signal transduction, gene regulation, and metabolic pathways. Understanding these interactions is essential for elucidating disease mechanisms, identifying therapeutic targets, and developing novel drugs. Protein purification and isolation are critical steps in studying protein-protein interactions, as they enable researchers to isolate individual proteins or protein complexes for detailed characterization and analysis. Also, advancements in proteomics technologies, such as mass spectrometry, protein microarrays, and yeast two-hybrid assays, have facilitated large-scale detection and analysis of protein-protein interactions.

Product Insights

Based on the product, consumables segment emerged as the dominant segment in the Global Protein Purification and Isolation market in 2023. Consumables, integral to protein purification and isolation processes, encompassed essential components like columns, resins, membranes, and reagents. These consumables, in tandem with purification instruments and systems, facilitated the separation, purification, and analysis of proteins from intricate biological samples. The demand for consumables remains steadfast across diverse domains including research, academic institutions, and biopharmaceutical sectors, propelling the segment's growth trajectory. Within laboratories, consumables are indispensable tools wielded by scientists and researchers in their quest to unravel the mysteries of proteins and their functions.

Columns, serving as the foundation of chromatographic separations, enable the isolation of specific proteins based on various characteristics such as size, charge, and affinity. Complementary to columns, resins play a pivotal role in capturing target proteins while membranes aid in filtration and concentration processes, ensuring the purity and integrity of protein samples. The significance of reagents cannot be overstated, as they catalyze specific biochemical reactions crucial for protein purification. These consumables collectively constitute the backbone of protein purification workflows, enabling researchers to extract, refine, and characterize proteins with precision and efficiency.

The prominence of the consumables segment underscores the indispensability of these materials in advancing scientific endeavors and biopharmaceutical innovations. As research endeavors intensify and biopharmaceutical development surges, the demand for consumables is poised to persist, underpinning the continued expansion of the Global Protein Purification and Isolation market.

Regional Insights

North America emerged as the dominant player in the Global Protein Purification and Isolation Market in 2023, holding the largest market share. This leadership position stems from a confluence of factors that fortify the region's prominence. Foremost among these is North America's robust biopharmaceutical industry, which serves as a cornerstone of innovation and development in protein purification and isolation technologies. The region boasts a well-established research infrastructure, comprising world-renowned academic institutions, research centers, and biotechnology hubs. This ecosystem fosters collaboration and drives advancements in protein purification methodologies, enhancing the competitiveness of North American enterprises on the global stage.

North America upholds stringent regulatory standards governing the biopharmaceutical sector, ensuring the safety, efficacy, and quality of protein-based therapeutics. Compliance with these standards instills confidence among stakeholders and bolsters North America's reputation as a reliable source of high-quality protein purification and isolation solutions. The presence of key market players within North America further cements its position as a dominant force in the global protein purification and isolation landscape. These industry leaders leverage their expertise, resources, and strategic partnerships to spearhead innovation, expand market reach, and drive growth within the region and beyond.

These factors culminate in North America's leadership in the Global Protein Purification and Isolation Market, underscoring the region's pivotal role in shaping the trajectory of this dynamic industry. As North America continues to foster innovation, collaboration, and regulatory compliance, its influence on the global protein purification and isolation market is expected to endure and evolve in the years to come.

Key Market Players

Thermo Fisher Scientific, Inc.

Merck KGaA

QIAGEN N.V

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

GE HealthCare Technologies Inc.

Promega Corporation

Norgen Biotek Corp.

Abcam Limited

Danaher Corporation

Report Scope:

In this report, the Global Protein Purification and Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Purification and Isolation Market, By Application:

Drug Screening Biomarker Discovery Protein-Protein Interaction Studies Diagnostics

Protein Purification and Isolation Market, By Product:

Instruments Consumables

Protein Purification and Isolation Market, By Technology:

Ultrafiltration Precipitation Chromatography Electrophoresis Western Blotting Others

Protein Purification and Isolation Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Purification and Isolation Market.

Available Customizations:

Global Protein Purification and Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Purification and Isolation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Drug Screening, Biomarker Discovery, Protein-Protein, Interaction Studies, Diagnostics)
  • 5.2.2. By Product (Instruments, Consumables)
  • 5.2.3. By Technology (Ultrafiltration, Precipitation, Chromatography, Electrophoresis, Western Blotting, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2023)
• 5.3. Market Map
  • 5.3.1. By Application
  • 5.3.2. By Product
  • 5.3.3. By Technology
  • 5.3.4. By Region

6. Asia Pacific Protein Purification and Isolation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Product
  • 6.2.3. By Technology
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Protein Purification and Isolation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Technology
  • 6.3.2. India Protein Purification and Isolation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Technology
  • 6.3.3. Australia Protein Purification and Isolation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Technology
  • 6.3.4. Japan Protein Purification and Isolation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Application
      • 6.3.4.2.2. By Product
      • 6.3.4.2.3. By Technology
  • 6.3.5. South Korea Protein Purification and Isolation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Application
      • 6.3.5.2.2. By Product
      • 6.3.5.2.3. By Technology

7. Europe Protein Purification and Isolation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Product
  • 7.2.3. By Technology
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Protein Purification and Isolation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Technology
  • 7.3.2. Germany Protein Purification and Isolation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Technology
  • 7.3.3. Spain Protein Purification and Isolation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Technology
  • 7.3.4. Italy Protein Purification and Isolation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Technology
  • 7.3.5. United Kingdom Protein Purification and Isolation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Technology

8. North America Protein Purification and Isolation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Product
  • 8.2.3. By Technology
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Protein Purification and Isolation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Technology
  • 8.3.2. Mexico Protein Purification and Isolation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Technology
  • 8.3.3. Canada Protein Purification and Isolation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Technology

9. South America Protein Purification and Isolation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Product
  • 9.2.3. By Technology
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Protein Purification and Isolation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Technology
  • 9.3.2. Argentina Protein Purification and Isolation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Technology
  • 9.3.3. Colombia Protein Purification and Isolation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Technology

10. Middle East and Africa Protein Purification and Isolation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Product
  • 10.2.3. By Technology
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Protein Purification and Isolation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Technology
  • 10.3.2. Saudi Arabia Protein Purification and Isolation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Technology
  • 10.3.3. UAE Protein Purification and Isolation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Technology
  • 10.3.4. Egypt Protein Purification and Isolation Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Application
      • 10.3.4.2.2. By Product
      • 10.3.4.2.3. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Protein Purification and Isolation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (In case of listed)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Merck KGaA
• 15.3. QIAGEN N.V
• 15.4. Bio-Rad Laboratories, Inc.
• 15.5. Agilent Technologies, Inc.
• 15.6. GE HealthCare Technologies Inc.
• 15.7. Promega Corporation
• 15.8. Norgen Biotek Corp.
• 15.9. Abcam Limited
• 15.10. Danaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer